Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Inception Sciences spins off first company, neurology-focused Inception 1

Executive Summary

Concurrent with its own creation, Inception Sciences Inc., a drug discovery incubator, has spun off its first company, Inception 1 Inc., to develop small molecules for neurodegenerative diseases. Inception 1 has received $5mm in its initial round of financing from Versant Ventures and one undisclosed investor.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Spin-Off
    • Venture Financing

Related Companies